Application 202334
- Type
- ANDA
- Sponsor
- PERRIGO R AND D
Related Records
Application Products
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LEVONORGESTREL | LEVONORGESTREL | TABLET;ORAL | 1.5MG | No | No |
NDC Listings For This Application
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0113-2003 | Option 2 | levonorgestrel | L. Perrigo Company | ANDA | Current |
| 0113-2003 | Option 2 | levonorgestrel | L. Perrigo Company | ANDA | Current |
| 11509-0067 | Preventeza | levonorgestrel | Combe Incorporated | ANDA | Current |
| 69953-514 | Morning After | Levonorgestrel | Rapha Pharmaceuticals, Inc. | ANDA | Current |
| 69953-514 | Morning After | Levonorgestrel | Rapha Pharmaceuticals, Inc. | ANDA | Current |
| 80584-100 | Stix Restart | levonorgestrel | Get Stix Inc. | ANDA | Current |